Q04771 (ACVR1_HUMAN) Homo sapiens (Human)
Activin receptor type-1 UniProtKBInterProSTRINGInteractive Modelling
509 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: D3DPA4; Pongo abelii: A0A6D2WS17; Gorilla gorilla gorilla: G3QKB3; Nomascus leucogenys: G1QJA7; Colobus angolensis palliatus: A0A2K5I8W2
Available Structures
79 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the ACVR1 (ALK2) kinase in complex with FKBP12 and the inhibitor E6201 |
Heteromer P62942; | 100.0 | 1×E26; 7×EDO; 2×SO4; | |||
| Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12 an… |
Heteromer P62942; | 100.0 | 1×TAK; 5×SO4; 3×PG4; | |||
| Crystal structure of the kinase domain of ACVR1 (ALK2) in complex with FKBP12 and MU1700 |
Heteromer P62942; | 100.0 | 1×7IO; 1×F; | |||
| Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin |
Heteromer P68106; | 100.0 | 8×FLC; 1×TAK; 13×EDO; | |||
| ALK2 antibody complex |
Heteromer | 100 | ||||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010920a | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 2×DMS; 2×2AI; 7×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010949a | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 1×TLA; 1×XK1; 5×SO4; 1×DMS; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010955a | homo-2-mer | 99.64 | 4×LU8; 13×EDO; 2×DMS; 6×SO4; 1×YV4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a | homo-2-mer | 99.65 | 4×LU8; 11×EDO; 2×DMS; 5×XHJ; 5×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a | homo-2-mer | 99.65 | 4×LU8; 12×EDO; 2×DMS; 7×XFV; 6×SO4; | |||
| Crystal structure of the ACVR1 kinase domain in complex with LDN-193189 | homo-2-mer | 99.66 | 2×LDN; 7×EDO; 6×FLC; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074484b | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 2×DMS; 1×TLA; 2×XKY; 6×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010926a | homo-2-mer | 99.65 | 4×LU8; 12×EDO; 2×DMS; 6×XGJ; 5×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010952a | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 2×DMS; 2×XK7; 6×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 2×XEJ; 5×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000275d | homo-2-mer | 99.65 | 3×LU8; 12×EDO; 2×DMS; 3×HVK; 6×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000884c | homo-2-mer | 99.64 | 4×LU8; 13×EDO; 2×DMS; 7×XK4; 6×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010948a | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 2×DMS; 1×TLA; 1×XJY; 6×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 1×TAR; 2×GLY; 6×SO4; 1×DMS; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010933a | homo-2-mer | 99.65 | 4×LU8; 13×EDO; 2×DMS; 7×SO4; 5×XJP; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010947a | homo-2-mer | 99.65 | 4×LU8; 12×EDO; 2×DMS; 1×TLA; 6×XJV; 5×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010944a | homo-2-mer | 99.64 | 4×LU8; 13×EDO; 2×DMS; 6×SO4; 2×XJM; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a | homo-2-mer | 99.64 | 4×LU8; 14×EDO; 2×DMS; 6×SO4; 2×XGY; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035128c | homo-2-mer | 99.64 | 4×LU8; 13×EDO; 2×DMS; 6×SO4; 1×LAC; | |||
| Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor… | homo-2-mer | 99.66 | 4×PO4; 2×507; 30×EDO; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with an Quinazolinone based ALK2 inhibitor … | homo-2-mer | 99.66 | 2×IR2; 6×SO4; 4×EDO; | |||
| Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor… | homo-2-mer | 100 | 4×SO4; 2×IYZ; 8×GOL; | |||
| Crystal structure of the kinase domain of the Q207E mutant of ACVR1 (ALK2) in complex with a 2-amin… | monomer | 99.68 | 1×A3F; 9×EDO; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117 | monomer | 99.65 | 1×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010953a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with PK012456b | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 2×T5V; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010914a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 2×HVB; 4×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 3×HV2; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000893d | monomer | 99.65 | 3×LU8; 9×EDO; 1×XHG; 1×DMS; 2×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c | monomer | 99.65 | 3×LU8; 9×EDO; 1×TLA; 2×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010921a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×TLA; 1×09V; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010957a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×XKV; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×TLA; 2×BYZ; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010913a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×SRT; 2×HUH; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000376d | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×TLA; 1×LGA; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a | monomer | 99.65 | 3×LU8; 7×EDO; 3×XGV; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035133b | monomer | 99.65 | 3×LU8; 8×EDO; 1×DMS; 1×TLA; 1×BAQ; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000274c | monomer | 99.65 | 3×LU8; 8×EDO; 1×DMS; 3×T5Y; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010954a | monomer | 99.65 | 3×LU8; 8×EDO; 1×DMS; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010923a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×TLA; 1×XHD; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010935a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a | monomer | 99.65 | 3×LU8; 7×EDO; 1×DMS; 1×TLA; 2×02A; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010937a | monomer | 99.65 | 3×LU8; 8×EDO; 1×DMS; 1×V1L; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a | monomer | 99.64 | 3×LU8; 9×EDO; 1×DMS; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010930a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000329d | monomer | 99.65 | 3×LU8; 8×EDO; 1×DMS; 2×XH7; 3×SO4; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2118 | monomer | 99.65 | 3×SO4; 1×EDO; 1×TAR; 3×Q5Z; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2009 | monomer | 99.65 | 3×M2Z; 2×SO4; 5×EDO; 1×NH4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010918a | monomer | 99.65 | 3×LU8; 7×EDO; 1×TLA; 5×XGS; 3×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010910a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 2×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010946a | monomer | 99.65 | 3×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with a Quinazolinone based ALK2 inhibitor w… | monomer | 99.66 | 1×EZB; 4×SO4; 10×EDO; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2304 | monomer | 99.66 | 1×U0C; 7×SO4; 4×EDO; | |||
| Crystal structure of human ALK2 kinase domain with R206H mutation in complex with RK-71807 | monomer | 99.66 | 1×C9U; 2×SO4; | |||
| XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b | monomer | 99.65 | 3×LU8; 8×EDO; 1×DMS; 2×PPI; 3×SO4; | |||
| Crystal structure of human ALK2 kinase domain with R206H mutation in complex with a bicyclic pyrazo… | monomer | 99.66 | 1×FH0; 9×SO4; 2×EDO; | |||
| Crystal structure of human ACVR1 (ALK2) kinase in complex with compound 3 | monomer | 99.66 | 6×SO4; 1×XQX; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound BI-9564 | monomer | 99.66 | 4×DIO; 1×5U6; 2×SO4; 3×EDO; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K3007 | monomer | 99.66 | 1×EDO; 1×SO4; 1×TLA; 1×MVE; | |||
| Crystal structure of human ALK2 kinase domain with R206H mutation in complex with RK-59638 | monomer | 99.66 | 1×9TO; 3×SO4; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854 | monomer | 99.66 | 1×B4B; 2×CA; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Momelotinib | monomer | 99.66 | 6×EDO; 1×C87; 7×SO4; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2158 | monomer | 99.66 | 1×QWQ; 1×DMS; | |||
| Crystal structure of the ACVR1 kinase in complex with a 2-aminopyridine inhibitor | monomer | 99.66 | 4×PO4; 10×EDO; 1×A3F; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with a Quinazolinone based ALK2 inhibitor w… | monomer | 99.66 | 1×EUN; 4×SO4; 2×EDO; | |||
| Crystal structure of the ACVR1 kinase in complex with LDN-213844 | monomer | 99.66 | 1×844; 3×FLC; 1×EDO; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149 | monomer | 99.66 | 1×MM8; 3×SO4; | |||
| Crystal structure of the kinase domain of ACVR1 (ALK2) with M4K2234 | monomer | 99.66 | 1×YEE; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2308 | monomer | 99.66 | 1×NH4; 1×TZX; 5×SO4; 11×EDO; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36. | monomer | 99.66 | 1×B4E; 2×EDO; | |||
| Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530) | monomer | 99.66 | 1×H8H; 1×K; 4×PO4; | |||
| Kinase domain of ALK2-K492A/K493A with LDN-193189 | monomer | 99.31 | 1×LDN; | |||
| Kinase domain of ALK2-K493A with AMPPNP | monomer | 99.65 | 1×ANP; 4×MG; | |||
| Kinase domain of ALK2-K492A/K493A with AMPPNP | monomer | 99.3 | 1×ANP; 8×MG; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6eix.1.A | monomer | 0.81 | 1×A3F; | 99.70 | ||